国际麻醉学与复苏杂志   2016, Issue (3): 8-8
    
右美托咪定给药途径的研究进展
刘清仁, 王亚军, 季永1()
1.无锡锡山人民医院
Research Progress on administration routes of Dexmedetomidine
 全文:
摘要:

【摘要】背景 右美托咪定(dexmedetomidine, Dex)是一种新型高选择性α2肾上腺素能受体激动剂,具有镇静、镇痛、抗焦虑及抗交感等作用,在临床上应用已很广泛,其给药途径也趋于多样化。目的 对有关Dex的论著进行归纳总结,以探讨其给药方式的应用前景。 内容 阐述了Dex复合局麻药应用于椎管内、外周神经及关节腔的安全性以及对局麻药作用效果的影响,此外还评价了通过静注、口服、肌注、皮下、鼻腔及直肠等途径给药的安全性及有效性。 趋向 Dex给药途径多样化在临床应用中具有广阔的前景。

关键词: α2受体激动剂;右旋美托咪定;给药途径
Abstract:

【Abstract】Background Dexmedetomidine(Dex) is a novel and highly selective a2-adrenoceptor agonist with sedative, analgesic, anxiolytic and antisympathetic properties. It is applied widely in clinic and tends to be diversified on administration rout. Objective To review and summarize the relevant studies and to discuss the application prospect of Dex on administration rout. Content We elucidate the safety of Dex and the influence of local anesthetic effect on spinal canal, peripheral nerve and intra-articular. In addition, we also evaluate the safety and validity of drug delivery by intravenous, oral, intramuscular injection, subcutaneous, intranasal and rectal Dex. Trend Dex has a broad prospect in clinical application because of diversity on administration rout.

Key words: a2-adrenoceptor agonist; Dexmedetomidine; administration route